Celastrol inhibits the growth of estrogen positive human breast cancer cells through modulation of estrogen receptor α.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Letters

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.canlet.2010.09.006PMID 20934245
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Celastrol, a Triterpene, Enhances TRAIL-induced Apoptosis through the Down-regulation of Cell Survival Proteins and Up-regulation of Death Receptors*

  2010cited by this paper
• Genomic actions of estrogen receptor alpha: what are the targets and how are they regulated?

  2009cited by this paper
• Tripterygium wilfordii Hook F Treatment for Idiopathic Refractory Nephrotic Syndrome in Adults: A Meta-Analysis

  2009cited by this paper
• Nuclear receptors: Genomic and non-genomic effects converge

  2009cited by this paper
• Triterpenoids as new promising anticancer drugs.

  2009cited by this paper
• Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.

  2009cited by this paper
• Celastrol binds to ERK and inhibits FcepsilonRI signaling to exert an anti-allergic effect.

  2009cited by this paper
• Adenovirus-mediated expression of dominant negative c-myb induces apoptosis in head and neck cancer cells and inhibits tumor growth in animal model.

  2008cited by this paper
• Pax9 mediated cell survival in oral squamous carcinoma cell enhanced by c‐myb

  2008cited by this paper
• Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer

  2008cited by this paper
• Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells

  2008cited by this paper
• Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression.

  2008cited by this paper
• Estrogen and MYB in breast cancer: potential for new therapies

  2008cited by this paper
• Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells

  2007cited by this paper
• Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.

  2007cited by this paper
• Preclinical Studies of Celastrol and Acetyl Isogambogic Acid in Melanoma

  2007cited by this paper
• Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid.

  2006cited by this paper
• Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators.

  2006cited by this paper
• Pure oestrogen antagonists for the treatment of advanced breast cancer.

  2006cited by this paper
• Cancer Statistics, 2006

  2006cited by this paper
• STEROIDRECEPTORSANDPROLIFERATIONIN THE HUMANBREAST Results and Discussion Distribution of ER in Normal Human Breast Lobules

  2006cited by this paper
• Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.

  2006cited by this paper
• Inhibition of NF-κB activation through targeting IκB kinase by celastrol, a quinone methide triterpenoid

  2006cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer.

  2005cited by this paper
• Estrogen-receptor biology: continuing progress and therapeutic implications.

  2005cited by this paper
• Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E.

  2005cited by this paper
• Apoptosis Induction in HL-60 Cells and Inhibition of Topoisomerase II by Triterpene Celastrol

  2003cited by this paper
• Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype.

  2003cited by this paper
• Smad4 as a Transcription Corepressor for Estrogen Receptor α*

  2003cited by this paper
• Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

  2002cited by this paper
• Induction of apoptosis in K562 cells by dominant negative c-myb.

  2002cited by this paper
• Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression.

  2002cited by this paper
• ERβ Inhibits Proliferation and Invasion of Breast Cancer Cells.

  2001cited by this paper
• ER beta inhibits proliferation and invasion of breast cancer cells.

  2001cited by this paper
• Estrogen receptor β in the breast: role in estrogen responsiveness and development of breast cancer

  2000cited by this paper
• Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer

  2000cited by this paper
• Estrogen receptor beta--a new dimension in estrogen mechanism of action.

  1999cited by this paper
• Tamoxifen in the treatment of breast cancer.

  1998cited by this paper
• Tamoxifen in the Treatment of Breast Cancer

  1998cited by this paper
• Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones.

  1996cited by this paper
• Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint

  1996cited by this paper
• Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene.

  1991cited by this paper
• pS2 expression and response to hormonal therapy in patients with advanced breast cancer.

  1991cited by this paper
• Strong association between c-myb and oestrogen-receptor expression in human breast cancer.

  1990cited by this paper
• A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor.

  1988cited by this paper
• The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer.

  1988cited by this paper

• An Inhaled Nanoemulsion Encapsulating a Herbal Drug for Non-Small Cell Lung Cancer (NSCLC) Treatment

  2025cites this paper
• Tripterygium Wilfordii PTM Sites Classification with Attention Mechanism

  2025cites this paper
• (2R,4aS,6aS,12bR,14aS,14bR)-N-(2-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)ethyl)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxamide

  2024cites this paper
• Exploring medicinal potential and drug delivery solutions of Celastrol from the Chinese "Thunder of God Vine"

  2024cites this paper
• Dual stimuli-responsive polymeric prodrug consisting of reversible covalent bonded celastrol for tumor targeted delivery

  2023cites this paper
• Withaferin A and Celastrol Overwhelm Proteostasis

  2023cites this paper
• (2R,4aS,6aS,12bR,14aS,14bR)10-Hydroxy-N-(4-((6-methoxyquinolin-8-yl)amino)pentyl)-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxamide

  2023cites this paper
• Nanoparticles based on polymers modified with pH-sensitive molecular switch and low molecular weight heparin carrying Celastrol and ferrocene for breast cancer treatment.

  2021cites this paper
• Tripterygium hypoglaucum (Lévl.) Hutch and Its Main Bioactive Components: Recent Advances in Pharmacological Activity, Pharmacokinetics and Potential Toxicity

  2021cites this paper
• Anti-Breast Cancer Terpenoids of Natural Origins

  2021cites this paper
• Synthesis, computational docking and biological evaluation of celastrol derivatives as dual inhibitors of SERCA and P-glycoprotein in cancer therapy.

  2021cites this paper
• Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application

  2020cites this paper
• Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone‐methide triterpenoid celastrol

  2020cites this paper
• Celastrol Inhibits Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Interleukin-6 via Downregulating Nuclear Factor-κB (NF-κB)

  2020cites this paper
• Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology.

  2020cites this paper
• Yuanhuatine from Daphne genkwa selectively induces mitochondrial apoptosis in estrogen receptor α-positive breast cancer cells in vitro

  2019cites this paper
• Celastrol Reverses Palmitic Acid-Induced Insulin Resistance in HepG2 Cells via Restoring the miR-223 and GLUT4 Pathway.

  2019cites this paper
• Celastrol Inhibits the Growth of Ovarian Cancer Cells in vitro and in vivo

  2019cites this paper
• Tripterine inhibits proliferation, migration and invasion of breast cancer MDA-MB-231 cells by up-regulating microRNA-15a

  2019cites this paper
• Dissecting celastrol with machine learning to unveil dark pharmacology.

  2019cites this paper
• Dihydrocelastrol exerts potent antitumor activity in mantle cell lymphoma cells via dual inhibition of mTORC1 and mTORC2.

  2018cites this paper
• Celastrol inhibits colorectal cancer cell proliferation and migration through suppression of MMP3 and MMP7 by the PI3K/AKT signaling pathway

  2018cites this paper
• Natural product modulators of human sensations and mood: molecular mechanisms and therapeutic potential.

  2018cites this paper
• Celastrol alleviates renal fibrosis by upregulating cannabinoid receptor 2 expression

  2018cites this paper
• Inhibitory effect of celastrol on cell viability of urinary bladder cancer cell line 5637 cells through JAK2/STAT3 signaling pathway

  2017cites this paper
• Novel celastrol derivatives with improved selectivity and enhanced antitumour activity: Design, synthesis and biological evaluation.

  2017cites this paper
• A mechanistic overview of herbal medicine and botanical compounds to target transcriptional factors in Breast cancer.

  2017cites this paper
• Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases

  2017cites this paper
• Estrogenic terpenes and terpenoids: Pathways, functions and applications

  2017cites this paper
• Pentacyclic triterpenoids: Discovery of new drugs with antitumour activity

  2017cites this paper
• Exosomal formulation enhances therapeutic response of celastrol against lung cancer.

  2016cites this paper
• Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms.

  2016cites this paper
• Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review

  2016cites this paper
• Different anticancer effects of Saxifragifolin A on estrogen receptor-positive and estrogen receptor-negative breast cancer cells.

  2015cites this paper
• Celastrol induces mitochondria-mediated apoptosis in hepatocellular carcinoma Bel-7402 cells.

  2015cites this paper
• Estrogenic endocrine disruptors: Molecular mechanisms of action.

  2015cites this paper
• Effects of Plants and Isolates of Celastraceae Family on Cancer Pathways.

  2015cites this paper
• Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment

  2015cites this paper
• α-Mangostin-induced apoptosis is mediated by estrogen receptor α in human breast cancer cells.

  2014cites this paper
• Celastrol and Attenuation of Tumor Growth in Systemic Malignancies: A Clinical Perspective

  2014cites this paper
• Multifunctional pentacyclic triterpenoids as adjuvants in cancer chemotherapy: a review

  2014cites this paper
• Celastrol Prevents Atherosclerosis via Inhibiting LOX-1 and Oxidative Stress

  2013cites this paper
• Derailed estrogen signaling and breast cancer: an authentic couple.

  2013cites this paper
• Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model

  2013cites this paper
• Effects of celastrol on human cervical cancer cells as revealed by ion-trap gas chromatography-mass spectrometry based metabolic profiling.

  2013cites this paper
• Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.

  2013cites this paper
• Triptolide Inhibits the Proliferation of Prostate Cancer Cells and Down-Regulates SUMO-Specific Protease 1 Expression

  2012cites this paper
• Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine

  2012cites this paper
• Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells.

  2012cites this paper
• Preparation, characterization, and assessment of the antiglioma effects of liposomal celastrol

  2012cites this paper
• Celastrol Inhibits Breast Cancer Cell Invasion via Suppression of NF-ĸB-mediated Matrix Metalloproteinase-9 Expression

  2011cites this paper
• The Main Anticancer Bullets of the Chinese Medicinal Herb, Thunder God Vine

  2011cites this paper
• Eur opean J ournal of Chem istry

  year unknowncites this paper